By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


G1 Therapeutics 

79 T.W. Alexander Drive
4501 Research Commons, Suite 100
Chapel Hill  North Carolina    U.S.A.
Phone: 919-213-9835 Fax: 919-741-5830



Company News
G1 Therapeutics (GTHX) Reports Second Quarter 2017 Financial Results And Recent Operational Highlights 8/9/2017 1:02:11 PM
G1 Therapeutics (GTHX) Makes Key Appointments To Management Team 8/3/2017 11:38:15 AM
G1 Therapeutics (GTHX) To Ring Nasdaq Stock Market Closing Bell On Wednesday, August 2, 2017 7/27/2017 10:58:38 AM
G1 Therapeutics (GTHX) Appoints Sir Andrew Witty To Board Of Directors 7/13/2017 8:17:16 AM
G1 Therapeutics (GTHX) Announces Closing Of Initial Public Offering 5/23/2017 10:41:14 AM
Cancer Biotech G1 Therapeutics (GTHX) Grabs $105 Million in IPO 5/17/2017 6:11:26 AM
G1 Therapeutics Announces Launch Of Initial Public Offering 5/8/2017 9:06:19 AM
Cancer Biotech G1 Therapeutics (GTHX) Files for $115 Million IPO 4/18/2017 6:36:42 AM
G1 Therapeutics Release: Biotech Initiates Three Drug Development Programs In Breast Cancer 1/10/2017 7:00:07 AM
G1 Therapeutics To Evaluate Trilaciclib (G1T28) In Combination With Immune Checkpoint Inhibitor In Small-Cell Lung Cancer 12/5/2016 8:45:09 AM